Defibrination syndrome: changing concepts and recognition of the low grade form.
D000347:Afibrinogenemia / Q000150:complications; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000941:Antigens / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000503:physiopathology; D001780:Blood Coagulation Tests; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D005165:Factor V / Q000096:biosynthesis; D005169:Factor VIII / Q000096:biosynthesis; D005337:Fibrin / Q000032:analysis / Q000096:biosynthesis; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000096:biosynthesis; D005342:Fibrinolysis; D006385:Hemagglutination Inhibition Tests; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011517:Prothrombin Time; D011863:Radioimmunoassay; D013917:Thrombin / Q000096:biosynthesis; D013921:Thrombocytopenia / Q000150:complications; D013925:Thromboplastin / Q000032:analysis
D000890:Anti-Infective Agents; D000941:Antigens; D005165:Factor V; D005169:Factor VIII; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D013925:Thromboplastin; D013917:Thrombin; D005341:Fibrinolysin